High Growth Tech Stocks To Watch In November 2024

In This Article:

Over the last 7 days, the United States market has dropped 1.2%, yet it remains up by 30% over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context of robust annual growth and recent volatility, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on future earnings potential.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

23.83%

24.32%

★★★★★★

Sarepta Therapeutics

23.90%

42.65%

★★★★★★

AsiaFIN Holdings

51.75%

82.69%

★★★★★★

Alnylam Pharmaceuticals

22.45%

70.66%

★★★★★★

Clene

78.50%

60.70%

★★★★★★

TG Therapeutics

34.66%

56.48%

★★★★★★

Alkami Technology

21.89%

98.60%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

ImmunityBio

Simply Wall St Growth Rating: ★★★★★☆

Overview: ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines to enhance the natural immune system against cancers and infectious diseases, with a market cap of approximately $3.73 billion.

Operations: ImmunityBio focuses on developing immune-enhancing therapies and vaccines for cancer and infectious diseases, generating revenue primarily from its biotechnology segment, which reported $7.33 million.

ImmunityBio's rapid revenue growth, forecasted at 72.9% annually, significantly outpaces the U.S. market average of 8.9%, indicating robust expansion within its sector. Despite current unprofitability, the company is expected to pivot to profitability with an impressive projected annual profit growth of 68.1%. This potential turnaround is underscored by recent clinical successes, notably the QUILT 3.032 study where ANKTIVA combined with BCG showed a 71% complete response rate in treating bladder cancer—data that could enhance regulatory submissions and market presence in Europe soon. ImmunityBio's commitment to R&D is evident as it continues to innovate in immunotherapy, leveraging cutting-edge science to improve patient outcomes which may well set a new standard within oncology treatment protocols.

NasdaqGS:IBRX Earnings and Revenue Growth as at Nov 2024
NasdaqGS:IBRX Earnings and Revenue Growth as at Nov 2024

Western Digital

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Western Digital Corporation is a global company that develops, manufactures, and sells data storage devices and solutions across various regions including the United States, China, Europe, and more, with a market cap of approximately $22.57 billion.

Waiting for permission
Allow microphone access to enable voice search

Try again.